Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-06-11

Clinical Trial Update: Study To Investigate The Effectiveness Of Pregabalin For Management Of Patients Undergoing Total Hip Replacement [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating pregabalin for pain management in patients undergoing total hip replacement; study terminated with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pregabalin (Pregabalin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Pain, Perioperative | Phase 3 | Status: TERMINATED | Results posted: 2013-06-11